Evidence map›Paper›PMID 25315771›Full record

ArticleThe Journal of biological chemistry2014

Catalytically relevant electrostatic interactions of cytochrome P450c17 (CYP17A1) and cytochrome b5.

Hwei-Ming Peng, Jiayan Liu, Sarah E Forsberg, Hong T Tran, Sean M Anderson, Richard J Auchus

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. CytochromeDrug metabolism and disposition: the biological fate of chemicals · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Catalytic modulation of human cytochromes P450 17A1 and P450 11B2 by phospholipid.The Journal of steroid biochemistry and molecular biology · 2018
    Article
  18. Article
  19. Article
  20. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic.The Journal of steroid biochemistry and molecular biology · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hwei-Ming PengFrom the Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine.
Jiayan LiuFrom the Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine.
Sarah E ForsbergFrom the Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine.
Hong T TranLife Sciences Institute, and.
Sean M AndersonFrom the Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine.
Richard J AuchusFrom the Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, the Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109 rauchus@med.umich.edu.

Funding

Activation of androgen biosynthesis and drug metabolism by cytochrome b5R01GM086596 · NIGMS · UT SOUTHWESTERN MEDICAL CENTER · PI RICHARD J. AUCHUS · 2009 to 2026
$4.8M
NIGMS NIH HHS R01 GM086596NIGMS NIH HHS R01-GM086596-04
6 · The paper itself

Abstract

Two acidic residues, Glu-48 and Glu-49, of cytochrome b5 (b5) are essential for stimulating the 17,20-lyase activity of cytochrome P450c17 (CYP17A1). Substitution of Ala, Gly, Cys, or Gln for these two glutamic acid residues abrogated all capacity to stimulate 17,20-lyase activity. Mutations E49D and E48D/E49D retained 23 and 38% of wild-type activity, respectively. Using the zero-length cross-linker ethyl-3-(3-dimethylaminopropyl)carbodiimide, we obtained cross-linked heterodimers of b5 and CYP17A1, wild-type, or mutations R347K and R358K. In sharp contrast, the b5 double mutation E48G/E49G did not form cross-linked complexes with wild-type CYP17A1. Mass spectrometric analysis of the CYP17A1-b5 complexes identified two cross-linked peptide pairs as follows: CYP17A1-WT: (84)EVLIKK(89)-b5: (53)EQAGGDATENFEDVGHSTDAR(73) and CYP17A1-R347K: (341)TPTISDKNR(349)-b5: (40)FLEEHPGGEEVLR(52). Using these two sites of interaction and Glu-48/Glu-49 in b5 as constraints, protein docking calculations based on the crystal structures of the two proteins yielded a structural model of the CYP17A1-b5 complex. The appositional surfaces include Lys-88, Arg-347, and Arg-358/Arg-449 of CYP17A1, which interact with Glu-61, Glu-42, and Glu-48/Glu-49 of b5, respectively. Our data reveal the structural basis of the electrostatic interactions between these two proteins, which is critical for 17,20-lyase activity and androgen biosynthesis.

Indexed as

Amino AcidsAmino Acid SequenceCatalytic DomainCross-Linking ReagentsCrystallography, X-RayCytochromes b5Escherichia coliEthyldimethylaminopropyl CarbodiimideGene ExpressionHumansKineticsModels, MolecularMolecular Sequence DataMutagenesis, Site-DirectedProtein BindingProtein MultimerizationAmino AcidsCross-Linking ReagentsCYP17A1 protein, humanCytochromes b5Ethyldimethylaminopropyl CarbodiimideRecombinant ProteinsSteroid 17-alpha-HydroxylaseAllosteric RegulationAndrogenCYP17A1Cytochrome b5Cytochrome P450Mass Spectrometry (MS)Protein Cross-linkingSteroidogenesis

Identifiers

PMID25315771
PMCPMC4256320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.